Covered recipient · General Payments record
SCOTT S STOERNER
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2018–2024
$5,171.81
- Reported across 205 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $558.43 | 34 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $306.94 | 22 |
| Acerta Pharma LLC | $88.42 | 5 |
| SOBI, INC | $37.48 | 1 |
| GlaxoSmithKline, LLC. | $27.80 | 1 |
| UCB, Inc. | $24.24 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $22.10 | 1 |
| Amgen Inc. | $19.65 | 1 |
| GENZYME CORPORATION | $18.35 | 1 |
| Teva Pharmaceuticals USA, Inc. | $13.45 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $7.37 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106167377 | CMS |
| ABBVIE INC. | $19.43 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106167379 | CMS |
| ABBVIE INC. | $10.43 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106167381 | CMS |
| ABBVIE INC. | $31.26 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106167383 | CMS |
| ABBVIE INC. | $9.82 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106167385 | CMS |
| ABBVIE INC. | $12.39 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106167387 | CMS |
| ABBVIE INC. | $12.31 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106167389 | CMS |
| ABBVIE INC. | $26.97 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106167391 | CMS |
| ABBVIE INC. | $7.89 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106167393 | CMS |
| ABBVIE INC. | $9.98 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106167395 | CMS |
| ABBVIE INC. | $21.08 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106167397 | CMS |
| ABBVIE INC. | $10.82 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106167399 | CMS |
| ABBVIE INC. | $8.40 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106167401 | CMS |
| ABBVIE INC. | $10.35 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106167403 | CMS |
| ABBVIE INC. | $29.19 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106167405 | CMS |
| ABBVIE INC. | $10.97 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106167407 | CMS |
| ABBVIE INC. | $11.10 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106167409 | CMS |
| ABBVIE INC. | $9.58 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106167411 | CMS |
| ABBVIE INC. | $10.24 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106167413 | CMS |
| ABBVIE INC. | $7.50 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106167415 | CMS |
| ABBVIE INC. | $12.12 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106167417 | CMS |
| ABBVIE INC. | $17.74 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106167419 | CMS |
| Amgen Inc. | $19.65 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117693592 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.82 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104281443 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.83 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105487455 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.71 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105229345 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.84 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104443450 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.22 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105448039 | CMS |
| GENZYME CORPORATION | $18.35 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139769764 | CMS |
| GlaxoSmithKline, LLC. | $27.80 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116704260 | CMS |
| Novartis Pharmaceuticals Corporation | $22.10 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087249721 | CMS |
| SOBI, INC | $37.48 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141416980 | CMS |
| Teva Pharmaceuticals USA, Inc. | $13.45 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151516033 | CMS |
| UCB, Inc. | $24.24 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143302731 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.